DICHLOROISOPROTERENOL

ID: ALA30816

Max Phase: Preclinical

Molecular Formula: C11H15Cl2NO

Molecular Weight: 248.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)NCC(O)c1ccc(Cl)c(Cl)c1

Standard InChI:  InChI=1S/C11H15Cl2NO/c1-7(2)14-6-11(15)8-3-4-9(12)10(13)5-8/h3-5,7,11,14-15H,6H2,1-2H3

Standard InChI Key:  VKMGSWIFEHZQRS-UHFFFAOYSA-N

Associated Targets(Human)

Sodium channel alpha subunits; brain (Types I, II, III) 374 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adrenergic receptor beta 1214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-1 adrenergic receptor 6630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-2 adrenergic receptor 11824 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Beta-1 adrenergic receptor 551 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-2 adrenergic receptor 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-1 adrenergic receptor 895 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-2 adrenergic receptor 1382 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.15Molecular Weight (Monoisotopic): 247.0531AlogP: 3.02#Rotatable Bonds: 4
Polar Surface Area: 32.26Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.51CX LogP: 2.88CX LogD: 0.80
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.86Np Likeness Score: -0.75

References

1. Solmajer T, Lukovits I, Hadzi D..  (1982)  Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain.,  25  (12): [PMID:7154001] [10.1021/jm00354a004]
2. Macchia B, Balsamo A, Breschi MC, Chiellini G, Macchia M, Martinelli A, Martini C, Nardini C, Nencetti S, Rossello A..  (1994)  The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists.,  37  (10): [PMID:7910217] [10.1021/jm00036a018]
3. el Tayar N, Carrupt PA, Van de Waterbeemd H, Testa B..  (1988)  Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.,  31  (11): [PMID:2903243] [10.1021/jm00119a004]
4. Kaiser C, Oh HJ, Garcia-Slanga BJ, Sulpizio AC, Hieble JP, Wawro JE, Kruse LI..  (1986)  6,7-Dichloro-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline . A structurally novel beta-adrenergic receptor blocking agent.,  29  (11): [PMID:2878080] [10.1021/jm00161a039]
5. McNeal ET, Lewandowski GA, Daly JW, Creveling CR..  (1985)  [3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.,  28  (3): [PMID:2579237] [10.1021/jm00381a019]
6. Subbaiah MAM, Meanwell NA..  (2021)  Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.,  64  (19.0): [PMID:34591488] [10.1021/acs.jmedchem.1c01215]

Source